KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Q3 2025 value amounting to $1.9 million.

  • Rigel Pharmaceuticals' Other Working Capital Changes rose 3409.74% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 2453.03%. This contributed to the annual value of $3.4 million for FY2024, which is 26747.81% up from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Other Working Capital Changes is $1.9 million, which was up 3409.74% from -$6.6 million recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Other Working Capital Changes peaked at $13.2 million during Q1 2025, and registered a low of -$13.9 million during Q2 2021.
  • In the last 5 years, Rigel Pharmaceuticals' Other Working Capital Changes had a median value of -$674000.0 in 2021 and averaged -$385263.2.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 341540.4% in 2021, then surged by 40890.09% in 2025.
  • Rigel Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$508000.0 in 2021, then tumbled by 137.99% to -$1.2 million in 2022, then surged by 370.89% to $3.3 million in 2023, then crashed by 101.34% to -$44000.0 in 2024, then soared by 4354.55% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, -$6.6 million for Q2 2025, and $13.2 million during Q1 2025.